Literature DB >> 25207583

Issues with radiofrequency heating in MRI.

Jihong Wang1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25207583      PMCID: PMC5711075          DOI: 10.1120/jacmp.v15i5.5064

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


× No keyword cloud information.
To the Editor: In recent years, the use of magnetic resonance imaging (MRI) has been increasing in patients with implanted devices, such as cardiac pacemakers and neurostimulators, which used to preclude the use of MRI owing to patient safety and device malfunction concerns. , , , , , In the past few years, however, more of these implant devices have become MR‐compatible and can function properly during MRI studies. For these devices, one of the remaining limiting factors and safety considerations is radiofrequency (RF) heating, particularly in the conductive part of the implanted device which may damage the surrounding tissues. To allow the use of MRI with these types of devices, manufacturers typically specify the conditions under which imaging sequences can be safely used, including the maximum specific absorption rate (SAR) values and gradient strengths. For SAR values, clinical users often rely solely on the SAR values reported by the MRI system for specific MRI sequences. Therefore, the accuracy and consistency of the SAR values reported by the MRI system are become more relevant and critical for patient safety. However, to the best of our knowledge, these SAR values are not routinely verified or validated independently by clinical users anywhere in the today's clinical practice. Although the physical principles of RF heating are simple and straightforward, accurate calculation of the SAR (measured in W/kg) is complicated by many factors, including patient size, heterogeneity of tissue conductivity, and differences in the RF power distribution profiles of the various MRI scanning sequences, as well as the specific scanning parameters. In general, SAR values increase with patient body weight. However, for the most part, the calculation of SAR values is proprietary for each MRI system manufacturer. Consequently, no independent validation or verification is available to clinical users, who must completely rely on the SAR value reported by the vendor. In a recent survey of the SAR values for clinical MRI spine studies at our institution, we found some inconsistencies and possible inaccuracies in the reported SAR values. As shown in Fig. 1, for the reported SAR values for the three‐plane localizer scans at 1.5 T, some of the SAR values for the localizer sequences were quite high (even beyond the US Food and Drug Administration safety limits). This was not expected, and was most likely due to a calculation error or a bug in the SAR value calculation and reporting program, rather than actual high SAR values in the scans.
Figure 1

Specific absorption rate (SAR) values of three‐plane localizer scans.

Specific absorption rate (SAR) values of three‐plane localizer scans. Additionally, we noticed some inconsistencies in the relationship between reported SAR values and patient body weight for the 3‐T systems from one MRI vendor. As shown in Fig. 2(a), the SAR values were negatively correlated with patient body weight, whereas in theory they should be positively correlated with body weight (as shown in Fig. 2(b) for the 1.5‐T scanners from the same vendor).
Figure 2

Specific absorption rate (SAR) values for T2 sagittal scans on 3‐T (a) and 1.5‐T systems (b). Note the negative correlation between SAR and patient body weight for scans done on the 3‐T systems compared with the positive correlation for scans done on the 1.5‐T systems.

Specific absorption rate (SAR) values for T2 sagittal scans on 3‐T (a) and 1.5‐T systems (b). Note the negative correlation between SAR and patient body weight for scans done on the 3‐T systems compared with the positive correlation for scans done on the 1.5‐T systems. Our survey results cast doubt on the accuracy and reliability of reported SAR values, and indicate that SAR reporting should be standardized to ensure consistency and reliability in reported SAR values, which are becoming more important for clinical decisions involving the use of MRI in patients with implanted devices. We hope to raise awareness of this issue among clinical users who currently completely rely on these reported SAR values. We also hope that this will be the first step to bring the medical physics community together to demand openness and standardization from MRI manufacturers in the calculation of SAR values, and that this will ultimately lead to some kind of independent validation of SAR values, as is currently done for radiation doses in CT studies.
  6 in total

1.  A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).

Authors:  Peter Thomas Burke; Hamid Ghanbari; Patrick B Alexander; Michael K Shaw; Marcos Daccarett; Christian Machado
Journal:  J Interv Card Electrophysiol       Date:  2010-01-29       Impact factor: 1.900

2.  Cardiac pacemaker: in vitro assessment at 1.5 T.

Authors:  Frank G Shellock; David S Fieno; Louise J Thomson; Thomas M Talavage; Daniel S Berman
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

3.  Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.

Authors:  Jennifer D Cohen; Heather S Costa; Robert J Russo
Journal:  Am J Cardiol       Date:  2012-08-23       Impact factor: 2.778

4.  Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.

Authors:  Robert J Russo
Journal:  Am Heart J       Date:  2013-01-28       Impact factor: 4.749

Review 5.  Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices.

Authors:  Nikolaos G Baikoussis; Efstratios Apostolakis; Nikolaos A Papakonstantinou; Ioannis Sarantitis; Dimitrios Dougenis
Journal:  Ann Thorac Surg       Date:  2011-04-30       Impact factor: 4.330

Review 6.  Safe magnetic resonance image scanning of the pacemaker patient: current technologies and future directions.

Authors:  Werner Jung; Vlada Zvereva; Bajram Hajredini; Sebastian Jäckle
Journal:  Europace       Date:  2012-01-10       Impact factor: 5.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.